Some trials show acute increases in GLP1 after a session of moderate exercise and longer-term training improves appetite control and glucose regulation
pylori regimens, including safety, accessibility, efficiency and restriction of antibiotic resistance

Standard titration schedule from trials 12-week escalation protocol: Weeks 1-4: 0.6mg weekly Initiation dose Body adapts to amylin effects Minimal side effects at this level Weight loss begins (modest) Weeks 5-8: 1.2mg weekly First dose increase (doubling) Gastric slowing becomes more noticeable Appetite suppression strengthens Accelerated weight loss Weeks 9-12: 1.8mg weekly Second increase Strong satiety effects More pronounced GI effects possible Approaching maximum efficacy Week 13+: 2.4mg weekly (maintenance) Target therapeutic dose Maximum weight loss velocity Maintained indefinitely Nausea typically resolved by this point (adapted) Why this schedule works: Gradual exposure reduces side effects 4-week intervals allow full adaptation Doubling steps (0.61.22.4) are tolerable Proven in hundreds of patients Balances speed with tolerability Use our peptide calculator and peptide dosing guide at SeekPeptides for precise calculations

Tirzepatide doesnt cause these issues, but it can expose or worsen them if theyre already present
PlexusDx Semaglutide Oral sits in the same category as MEDVis compounded tablet (compounded oral GLP-1, not FDA-approved as a finished product), at $289/mo month-to-month, or from $249/mo on the 6-month plan with consultation, medication, and shipping included and PlexusDx Microdose GLP-1 Protocol offers a flat $129/month entry-level option in capsule, troche, lozenge, or sublingual delivery
It's possible that, in the future, we'll learn something that makes it either a much better or much worse option than initially assumed